Cargando…
6-Shogaol Antagonizes the Adipocyte-Conditioned Medium-Initiated 5-Fluorouracil Resistance in Human Colorectal Cancer Cells through Controlling the SREBP-1 Level
The resistance of colorectal cancer (CRC) to chemotherapy, e.g., 5-fluorouracil (5-FU), is an impediment to successful cancer treatment. Although many mechanisms have been proposed to explain the occurrence of resistance, little is known concerning the role of the adipocyte-containing microenvironme...
Autores principales: | Lee, Ko-Chao, Wu, Kuen-Lin, Yen, Chia-Kung, Chen, Cheng-Nan, Chang, Shun-Fu, Huang, Wen-Shih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537026/ https://www.ncbi.nlm.nih.gov/pubmed/34685438 http://dx.doi.org/10.3390/life11101067 |
Ejemplares similares
-
The antagonism of 6-shogaol in high-glucose-activated NLRP3 inflammasome and consequent calcification of human artery smooth muscle cells
por: Chen, Te-Chuan, et al.
Publicado: (2020) -
Inhibition of NLRP3 by Fermented Quercetin Decreases Resistin-Induced Chemoresistance to 5-Fluorouracil in Human Colorectal Cancer Cells
por: Lee, Ko-Chao, et al.
Publicado: (2022) -
Glucuronidation of [6]-shogaol, [8]-shogaol and [10]-shogaol by human tissues and expressed UGT enzymes: identification of UGT2B7 as the major contributor
por: He, Liangliang, et al.
Publicado: (2018) -
6-Shogaol enhances the anticancer effect of 5-fluorouracil, oxaliplatin, and irinotecan via increase of apoptosis and autophagy in colon cancer cells in hypoxic/aglycemic conditions
por: Woźniak, Marta, et al.
Publicado: (2020) -
The possibility of using shogaol for treatment of ulcerative colitis
por: Hassan, Snur MA, et al.
Publicado: (2018)